Archive for October, 2009

Facebook wins $712-million in damages in spammer case

October 31st, 2009

TORONTO – Facebook has won 712 million dollars in damages after a California court ruled against a spammer for trying to get personal information from the users of the social networking website.

The court ordered Sanford Wallace to pay Facebook the money after the company complained [...]

Intuit cuts CEO’s compensation by 51 percent as profit narrows in 2009

October 31st, 2009

Intuit cuts CEO’s compensation by about half

MOUNTAIN VIEW, Calif. — Intuit Inc. gave CEO Brad Smith compensation valued at $3.6 million, according to an Associated Press calculation of figures disclosed in a regulatory filing made Friday. The compensation was about half of what he earned last year, as the financial software maker’s profit took a [...]

Bill Gates among Obama’s Oval Office visitors

October 31st, 2009

more images

more images

Gates among Obama’s Oval Office guests
WASHINGTON — Microsoft co-founder Bill Gates was among those landing Oval Office visits with President Barack Obama during his first months in office.
The White House late Friday afternoon released a partial list of visitors to the White House since Obama took office in January. The list identified two [...]

Targeted gene conversion induced by triplex-directed psoralen interstrand crosslinks in mammalian cells

October 30th, 2009

Correction of a defective gene is a promising approach for both basic research and clinical gene therapy. However, the absence of site-specific targeting and the low efficiency of homologous recombination in human cells present barriers to successful gene targeting. In an effort to overcome these barriers, we utilized triplex-forming oligonucleotides (TFOs) conjugated to a DNA interstrand crosslinking (ICL) agent, psoralen (pTFO-ICLs), to improve the gene targeting efficiency at a specific site in DNA. Gene targeting events were monitored by the correction of a deletion on a recipient plasmid with the homologous sequence from a donor plasmid in human cells. The mechanism underlying this event is stimulation of homologous recombination by the pTFO-ICL. We found that pTFO-ICLs are efficient …

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells

October 30th, 2009

Authors: J L Dembinski, E L Spaeth, J Fueyo, C Gomez-Manzano, M Studeny, M Andreeff
& F C Marini (Source: Cancer Gene Therapy)

Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice

October 30th, 2009

Authors: R Zhang, L Ma, M Zheng, J Ren, T Wang, Y Meng, J Zhao, L Jia, L Yao, H Han, K Li
& A Yang (Source: Cancer Gene Therapy)

[Cell and ex vivo gene therapy: advances in the treatment of central nervous system disorders.]

October 30th, 2009

CONCLUSIONS. Ex vivo cell therapy and gene therapy have helped to expand our knowledge about plasticity and the mechanisms and factors that promote cell integration within the central nervous system. Although behavioural improvements have been reported in animal and human models, further work is still required on these studies to clear up a number of dubious points. Ex vivo cell therapy and gene therapy in the nervous system constitute an important methodological tool with therapeutic possibilities that deserve further study.
PMID: 19859890 [PubMed - in process] (Source: Revista de Neurologia)

Las Vegas Sands, MetLife, Manitowoc, Novatel Wireless are among big market movers Friday

October 30th, 2009

Las Vegas Sands, MetLife, Manitowoc are big movers

NEW YORK — The following stocks were among those that moved substantially or traded heavily Friday on the New York Stock Exchange:
NYSE:
Alcatel-Lucent, down 48 cents at $3.69
The telecommunications equipment maker saw its net loss widen in the third quarter as European phone companies cut back on spending.
Harman International [...]

Novatel shares plunge after 4th-quarter outlook disappoints despite strong 3rd quarter

October 30th, 2009

Novatel shares tumble after 4Q outlook disappoints

NEW YORK — Shares of Novatel Wireless Inc. tumbled Friday after the wireless high-speed Internet service provider posted a disappointing outlook for the fourth quarter.
Novatel’s third-quarter results reported Thursday were strong, topping analyst estimates. But investors spooked by the fourth-quarter outlook sent shares down $3.32, or 27.3 percent, to [...]

Mass. Dem. Senate hopefuls stake out varying positions on casinos as state weighs gaming plans

October 30th, 2009

Mass. Dem. Senate hopefuls differ on casino gaming

BOSTON — The four Democratic candidates vying for the late Edward Kennedy’s Senate seat have finally found something they can disagree on: casino gambling.
After concurring on everything from expanded health care to opposing an Afghanistan troop build-up, Attorney General Martha Coakley, U.S. Rep. Michael Capuano, Alan Khazei and [...]

CDC Software expects 3rd-quarter earnings to surpass Wall Street’s estimates

October 30th, 2009

CDC Software sees 3Q profit above expectations

ATLANTA — Business software developer CDC Software Corp. said Friday it expects its earnings to surpass Wall Street’s expectations in the third quarter.
The company forecast earnings of $5.8 million to $6.4 million for the third quarter. Excluding items, CDC expects earnings of 33 cents per share for the three [...]

10 Best Halloween Facebook Apps

October 30th, 2009

Are you all set for the scariest Halloween party? If you are done with your Halloween costumes, here’s some cool idea to dash off your Halloween. Most of you on Facebook spend hours grilling what’s on your mind stuff. Well, there are more than enough spooky, scary Facebook apps for Halloween that you can afford [...]

Sony reports quarterly red ink, trims full-year loss forecast amid gradual recovery from slump

October 30th, 2009

more images

more images

Sony stays in the red, trims annual loss forecast
TOKYO — Sony reported a smaller-than-expected 26.3 billion yen ($289 million) quarterly loss as cost cuts combined with healthy sales of PlayStation 3 game consoles and Michael Jackson hits helped it inch toward recovery.
The Japanese electronics and entertainment giant has been battered by the global [...]

AVG Free Download – Antivirus Software for Halloween

October 30th, 2009

Is you PC scaring you this Halloween? Most of you must have been googling for Halloween costumes for quite sometime now. If you weren’t lucky enough, you must have landed up in malicious zone. Reports from security software solution provider Trend Micro suggests that trustworthy, legitimate sites have been infected and you might land up [...]

Japan’s Toshiba ekes out small profit in 2nd quarter on cost-cutting, higher memory chip sales

October 30th, 2009

more images

more images

Toshiba ekes out small profit in 2nd quarter
TOKYO — Toshiba Corp. said Friday it eked out a small profit in the July-September quarter on cost-cutting and higher sales of memory chips.
The Japanese electronics company reported a net profit of 100 million yen ($1.1 million) for the fiscal second quarter, up from a net [...]

Calif. court awards Facebook $711 million in damages in case vs. Web marketer Sanford Wallace

October 30th, 2009

more images

more images

Web marketer ordered to pay Facebook $711M damages
LOS ANGELES — Facebook said Thursday a California court has awarded the social networking Web site $711 million in damages in an anti-spam case against Internet marketer Sanford Wallace.
Facebook sued Wallace for accessing users’ accounts without their permission and sending phony posts and messages. The company [...]

Of mice and men: Stem cells and ethical uncertainties

October 30th, 2009

The recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University’s Berman Institute of Bioethics. (2009-10-30)

International Stem Cell Corporation CEO Kenneth Aldrich Speaks at Stem Cells USA & Regenerative Medicine Congress

October 30th, 2009

/To display this email in a browser, please click here







conference details
Conference:
Day 1
Nov 17, 8:30am – 5:30pm
Day 2
Nov 18, 8:30am – 5:30pm
Pre-conference workshop:
Nov 16, 9am – 4:30pm

Register now and save 15%
Add this to my calendar

or call +1 212 379 6320


our speakers
Dr Anthony Atala
Director
Wake Forest Institute for Regenerative Medicine
Dr Story Landis
Head of the Stem Cell Task Force
National Institute of Health
Dr Ruth McKernan
Chief Scientific Officer
Pfizer
Mr Paul Grayson
President & CEO
Fate Therapeutics
Dr Yukio Hasegawa
President & CEO
CellSeed

Dear Colleague,

Kenneth Aldrich, Chairman and Chief Executive Officer of International Stem Cell Corporation (ISCO.OB) is speaking at Stem Cells USA & Regenerative Medicine Congress on the topic of “Is there a correct business model for regenerative medicine?” and is pleased to extend a 15% discount on your registration.

> Register now and save 15%

Key topics include:

  • Funding and partnership models
  • Stem cells as tools in predicting drug toxicity
  • Stems cells as tools in drug discovery – target identification and validation
  • Novel strategies for study of disease
  • Commercialization challenges
  • Regulatory updates & strategies to overcome regulatory hurdles
  • Enhanced production & manufacturing systems
  • Big pharma perspective on future commercialization of stem cell therapeutics
  • The challenge of commercialization
  • Cardiovascular stem cell therapeutics
  • Skin, bone and hair stem cell therapeutics

> Download the brochure

Be among the following already registered to attend:

Biotec GmbH; WuXi AppTec, Inc; Healthpoint, Ltd.; University of Nebraska Medical Center; Lonza Walkersville; LifeCell Corporation; Sartorius Stedim Biotech; Baxter Healthcare Corporation; Roche; Biomade; ECBio Sa; Medeia Therapeutics Ltd; ECBio Sa; Manufacturing Technology; BD Technologies; Miltenyi Biotec GmbH; Aastrom Biosciences; BD; NFCR; Mars Innovation; Pfizer; Tarix Pathfinder Pharmaceuticals; Vitrolife Sweden AB; AstraZeneca R&D; University of Minnesota;
American Type Culture Collection; Advenced Technologies & Regenerative Medicine LLC; Invetech, Inc; Medrad, Inc; Cytograft;Theregen;GliaMed,Inc.; Roche; Txcell; BioTime;Stem Cell Therapeutics Corp.; Centocor;Cellerant Therapeutics; Genzyme; Darpha; Safeguard Scientifics; Wake Forest Institute for Regenerative Medicine; Novitas Capital; Baxter; Bay City Capital; Fate Therapeutics;Cell Seed;Proteus Venture Partners; TVM Capital; Organogenesis; The Havard Stem Cell Institute; National Institute of Health; CONNECT; Bioengineering Institute;Stratatech Corporation; Angioblast; Pfizer;Harvard Stem Cell Institute; Cellerix; Merck Research Laboratories; Athersys, Inc.; Advanced BioHealing; Tengion; Food and Drug Administration Center for Biologics Evaluation and Research; Juventas Therapeutics Inc.; Harvard Medical School; Haecker Consulating; University of Pittsburgh School of Medicine; International Stem Cell Corporation (ISCO.OB);Pervasis Therapeutics; GliaMed, Inc.; Novocell; California Stem Cell; University of Minho; Garnet BioTherapeutics; Athersys, Inc.; Drexel University College of Medicine; Advanced BioHealing; Johnson & Johnson; Panacea Biotec Limited and more!

> Learn more about the event

Will you be there to do business and strategize with senior level executives from the leading pharma, biotechs and government organizations?

> Register now and start networking!

or call +1 212 379 6320

Your voucher code is: KA
sponsored by


Created and delivered by Terrapinn

Off-Topic: Shades of Moby Dick

October 30th, 2009

Stories are told from time to time and then retold and retold about whales attacking sailboats. Some of them sound fanciful and are third and fourth hand.Here is a current account of what appears to be a genuine attack by whales or whales on a sailboat yesterday off the Baja California coast. The boat sank in a matter of minutes but no one was seriously injured. This is the first verifiable whale

Examining Gene Therapy As Treatment For Blindness

October 30th, 2009

Reporting in The Lancet, doctors found success in treating Leber’s congenital amaurosis, a rare type of blindness, with gene therapy. Study author Katherine High explains how injecting a gene-carrying virus into the eye has improved vision in a handful of patients.» E-Mail This     » Add to Del.icio.us (Source: NPR Health and Science)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.







Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Web Design by PlatinumShore.com & Web Hosting by TradeWebHosting.com